Serial #97901450
LIVE

Serial Number

97901450

Owner

Abbott Diabetes Care Inc.

Attorney

Michele H. Bowman

Filing Date

Apr 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97901450 Trademark

Serial Number: 97901450

Serial #97901450 is a trademark filed by Abbott Diabetes Care Inc. on April 21, 2023. The trademark is classified under Class 9 (Computers & Electronics). The application is currently pending registration.

Owner Contact Info

Abbott Diabetes Care Inc.

1420 Harbor Bay Parkway
Alameda, CA 94502

Entity Type: 03

Trademark Details

Filing Date

April 21, 2023

Registration Date

Not Registered

Published for Opposition

June 17, 2025

Goods & Services

Sensors for monitoring analyte levels for non-medical purposes; sensors for measuring analyte levels for non-medical purposes; sensors for monitoring analyte concentrations for non-medical purposes; sensors for determination of analyte concentrations for non-medical purposes; sensors used to measure and provide information related to analyte concentrations for non-medical purposes; sensors for gathering analyte concentration data for non-medical purposes; downloadable medical software and mobile applications for receiving, viewing, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, analyzing, logging and benchmarking analyte data, diabetes management data, diabetes management information, nutrition-related data, nutrition information, health-related data, health information, disease management data, disease management information, wellness-related data, and wellness information; downloadable software for capturing, measuring, tracking, and monitoring data for use with insulin delivery devices, insulin pens, namely, insulin injectors, and insulin pen caps to provide predictions and recommendations based on analyte levels for insulin dosage and medicament delivery in the field of diabetes management; downloadable Software as a Medical Device (SaMD) for managing prediabetes and diabetes by monitoring biological analytes; downloadable Software as a Medical Device (SaMD) for managing diabetes by monitoring glucose, ketone, and lactate levels; downloadable Software as a Medical Device (SaMD) for managing insulin dosage as part of diabetes management; downloadable mobile applications for capturing, measuring, tracking, and monitoring data for use with insulin delivery devices, insulin pens, namely, insulin injectors, and insulin pen caps to provide predictions and recommendations based on analyte levels for insulin dosage and medicament delivery in the field of diabetes management; downloadable software for receiving, viewing, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, analyzing, logging and benchmarking analyte data, diabetes management data, diabetes management information, nutrition-related data, nutrition information, health-related data, health information, disease management data, disease management information, wellness-related data, and wellness information in the field of medical diagnostics; downloadable mobile applications for receiving, viewing, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, analyzing, logging and benchmarking analyte data, diabetes management data, diabetes management information, nutrition-related data, nutrition information, health-related data, health information, disease management data, disease management information, wellness-related data, and wellness information in the field of medical diagnostics; downloadable software for managing health data; downloadable mobile applications for managing health, wellness, diabetes, and nutrition data; downloadable software for managing health, wellness, diabetes, and nutrition data; downloadable software for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing analyte data; downloadable mobile applications for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing analyte data; downloadable medical software for managing disease; downloadable mobile applications for managing disease; downloadable software for facilitating communication and collaboration between clinicians, caregivers, and patients; downloadable software for enabling users to receive personalized recommendations related to health, wellness, diabetes management, and nutrition; downloadable mobile applications for enabling users to receive personalized recommendations related to health, wellness, diabetes management, and nutrition; downloadable software for providing education in the fields of health, wellness, diabetes management, and nutrition; downloadable mobile applications for providing education in the fields of health, wellness, diabetes management, and nutrition; downloadable software to facilitate social networking in the fields of health, wellness, diabetes management, and nutrition; downloadable mobile applications to facilitate social networking in the fields of health, wellness, diabetes management, and nutrition; downloadable software to facilitate support and sharing of information the fields of health, wellness, diabetes management, and nutrition; downloadable mobile applications to facilitate support and sharing of information in the fields of health, wellness, diabetes management, and nutrition; downloadable software development kits (SDK) for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing analyte data; downloadable application programming interface (API) software for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing analyte data; downloadable software development kits (SDK) in the fields of health, wellness, diabetes management, and nutrition; downloadable application programming interface (API) software in the fields of health, wellness, diabetes management, and nutrition; downloadable software and mobile applications for use with analyte monitoring instruments

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 12, 2026 EXRA
SOU EXTENSION 1 GRANTED
Feb 11, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 11, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 11, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 12, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 17, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 15, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 9, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 9, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 16, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 16, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 16, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 15, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 15, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 19, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2023 NWOS
NEW APPLICATION ENTERED
Apr 25, 2023 NWAP